|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06618 JD HEALTH
Nominal 
28.200 +0.150 (+0.535%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Turnover | 28,343,961 | 4.550% | 27,110,336 | 20,225,212 | 13,637,832 | 8,777,490 |
| Cost of Sales | (21,644,018) | 3.524% | (20,907,336) | (15,810,653) | (10,330,373) | (6,559,923) |
| Gross Profit | 6,699,943 | 8.011% | 6,203,000 | 4,414,559 | 3,307,459 | 2,217,567 |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 10,409 | -- | (64,662) | (11,025) | (9,831) | (5,704,774) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (40,806) | 26.739% | (32,197) | (48,566) | (40,531) | (8,607) | |
| Profit / (Loss) before Taxation | 2,439,342 | 33.208% | 1,831,226 | 377,346 | (345,302) | (5,257,325) | |
| Taxation | (404,964) | 50.413% | (269,234) | (154,388) | (108,911) | (103,590) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 2,804 | -- | (634) | 594 | (931) | 2,163 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 2,037,182 | 30.475% | 1,561,358 | 223,552 | (455,144) | (5,358,752) | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Net Finance Costs / (Income) | (985,491) | 5.732% | (932,068) | (215,770) | (228,999) | (58,582) |
| Depreciation & Amortisation | 103,218 | -4.366% | 107,930 | 50,984 | 25,810 | 8,591 |
| Directors' Emoluments | -- | -- | -- | -- | -- | 7,030 |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | Unqualified |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| EPS (cts) | 65.000 | 30.000% | 50.000 | 7.000 | -15.000 | -249.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 16.344 | -- | 15.309 | 13.326 | 12.420 | -- |
| Remarks: | Real time quote last updated: 20/12/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 2,037,182 |
| %Change | 30.475% |
| EPS / (LPS) | RMB 0.650 |
| NBV Per Share (¥) | RMB 16.344 |